Inicio › Leucemia › Illinois › Chicago
Ensayos clínicos de Leucemia en Chicago, IL
16 estudios para Leucemia buscan participantes en centros de Chicago y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
ReclutandoFase 1/2
- The University of Chicago Medical Center, Chicago
Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)
ReclutandoFase 3
- Research Site, Chicago
Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell Malignancies
ReclutandoFase 1/2
- University of Chicago, Chicago
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
ReclutandoFase 1
- Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
ReclutandoFase 1/2
- Research Site, Chicago
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
ReclutandoFase 2
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Mosaic Trial for Stem Cell Transplant Recipients
Reclutando
- Northwestern University Feinberg School of Medicine, Chicago
Study of Chemotherapy-Free Induction Regimen for Ph+ Acute Lymphoblastic Leukemia With Inotuzumab Ozogamicin (InO)
ReclutandoFase 2
- University of Chicago Medical Center, Chicago
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
ReclutandoEstudio observacional
- Lurie Children's Hospital-Chicago, Chicago
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
ReclutandoFase 1/2
- University of Illinois at Chicago Cancer Center, Chicago
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
ReclutandoFase 1
- Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago
CApivasertib, Venetoclax And Low-intensity chemotheRapY for Adults With ALL/LBL
ReclutandoFase 1/2
- University of Chicago Medicine Comprehensive Cancer Center, Chicago
Spiritual Care Intervention in Adult Patients Diagnosed With Acute Leukemia
Reclutando
- UChicago Medicine Comprehensive Cancer Center, Chicago
Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care
Reclutando
- University of Chicago Comprehensive Cancer Center, Chicago
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
ReclutandoEstudio observacional
- Massive Bio SYNERGY-AI site, Chicago
A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome
ReclutandoFase 1
- Northwestern Medicine - Northwestern Memorial Hospital Galter Pavilion, Chicago
Más información sobre Leucemia en MedlinePlus
Ensayos de Leucemia en otras ciudades
- Houston, TX28 estudios
- Boston, MA25 estudios
- New York City, NY19 estudios
- Los Angeles, CA16 estudios
- Durham, NC13 estudios
- Philadelphia, PA12 estudios
- Columbus, OH12 estudios
- Nashville, TN12 estudios
- Baldwin Park, CA12 estudios
- Milwaukee, WI11 estudios
- Seattle, WA11 estudios
- Aurora, CO10 estudios
Otros estudios en Chicago
- Cáncer de pulmón de células no pequeñas62 estudios
- Cáncer de seno58 estudios
- Cáncer (todos los tipos)53 estudios
- Cáncer metastásico45 estudios
- Cáncer de próstata45 estudios
- Obesidad42 estudios
- Cáncer de pulmón41 estudios
- Cáncer de ovario36 estudios
- Accidente cerebrovascular35 estudios
- Fallo cardíaco32 estudios
- Cáncer del colon y del recto32 estudios
- Sobrepeso28 estudios
De ClinicalTrials.gov, datos obtenidos el 30 sept 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.